Other / Other / MRI

Pilocytic astrocytoma

Pilocytic astrocytomas are WHO grade 1 CNS tumors that typically present in children (70% occur in first two decades of life) with symptoms related to mass effect and raised intracranial pressure, particularly when located in the posterior fossa with associated hydrocephalus.

Key Images

Patient A

Patient A

Patient A

Pilocytic astrocytoma (path proven)

Same Patient

Brain Stem

Supratentorial

Suprasellar

Craniocervical junction

Craniocervical junction

Midbrain

Look For First
  • Large cystic lesion (often 60-70% of cases) with brightly enhancing mural nodule—the classic appearance
  • T2 hyperintense solid component with vivid contrast enhancement on T1 post-gadolinium
  • Midline cerebellar location with well-circumscribed margins in a young patient
  • Calcification present in ~20% of cases, visible on T2*/GRE/SWI as signal loss
Key Image Findings
  • T1 solid component is iso- to hypointense compared to adjacent brain; cystic component shows fluid signal unless hemorrhagic.
  • T1 contrast-enhanced (gadolinium) shows vivid enhancement of the solid component with ~50% of cases also demonstrating cyst wall enhancement; however, thin enhancing walls may not contain tumor cells.
  • T2/FLAIR: solid component hyperintense; cystic component shows high fluid signal.
  • T2*/GRE/SWI demonstrates signal loss if calcification or hemorrhage is present (up to 20% of cases have calcification).
  • DWI/ADC: solid components typically show facilitated diffusion; low ADC values reported in BRAF V600E mutant tumors.
  • MR spectroscopy shows elevated choline and lactate peaks.
  • MR perfusion demonstrates low to moderate relative cerebral blood volume (rCBV).
  • Most tumors (67%) present as a large cystic lesion with a brightly enhancing mural nodule, though heterogeneous mixed solid/cystic variants (16%) and completely solid tumors (17%) also occur.
Differential Diagnosis
  • Hemangioblastoma (more common in adults, usually associated with VHL in children): cyst wall typically does not enhance, no calcifications, smaller mural nodule with angiographic contrast blush distinguishes it.
  • High-grade astrocytoma with piloid features (especially in adults and NF1 patients): has significantly worse prognosis and more aggressive imaging appearance with greater heterogeneity.
  • Medulloblastoma (typically 2-6 years old): arises from midline (vermis/roof of fourth ventricle) rather than cerebellar hemisphere, shows low ADC values.
  • Atypical teratoid/rhabdoid tumor (AT/RT): presents as larger heterogeneously enhancing mass with more aggressive features.
  • Ependymoma: tends to fill and distend the fourth ventricle with protrusion through Luschka and Magendie foramina; large cystic component less common.
  • Ganglioglioma and pleomorphic xanthoastrocytoma (PXA): considered in differential but have distinct pathologic and imaging features.
Discussion

Pilocytic astrocytomas are WHO grade 1 tumors with excellent prognosis in children (>95% 10-year survival after complete resection), though fibrillary variants and adult presentations (50% 5-year survival) have worse outcomes.

Strong association with neurofibromatosis type 1: up to 20% of NF1 patients develop pilocytic astrocytomas (typically optic pathway involvement), and approximately one-third of optic nerve pilocytic astrocytomas have associated NF1.

The classic cyst-with-mural-nodule morphology results from increased VEGF expression promoting angiogenesis and vascular permeability; some surgeons advocate resecting only the mural nodule since non-enhancing cyst walls are typically non-neoplastic.

Nearly all pilocytic astrocytomas (70%) harbor BRAF alterations (or NF1, FGFR1, KRAS mutations) affecting the MAPK pathway and often respond to targeted MEK inhibition; importantly, they lack IDH and TP53 mutations.

Incomplete resection, unresectable tumors, or recurrent disease are treated with radiotherapy (>70% 10-year progression-free survival) or MEK inhibitors.

Cerebellar location is most common (60%); optic pathway involvement occurs in 25-30% particularly in NF1; adult pilocytic astrocytomas tend to be supratentorial and more heterogeneous with calcification, hemorrhage, and necrosis.

Reporting Pearls

Report the location, size of cystic component (which is often non-neoplastic), presence and enhancement pattern of the mural nodule, degree of hydrocephalus if present, and any calcification or hemorrhage; note that enhancing cyst walls may be present but do not necessarily contain tumor cells, particularly if thin—these details guide surgical planning regarding resection extent.

Pitfalls
  • Mistaking enhancing cyst wall as tumor involvement: non-neoplastic cyst walls may enhance (~50% of cases); intraoperative findings often clarify which walls are truly neoplastic.
  • Confusing pilocytic astrocytoma with high-grade astrocytoma with piloid features in adults or NF1 patients: the latter has terrible prognosis and more aggressive imaging features; NF1-associated high-grade cerebellar tumors historically misclassified as pilocytic astrocytomas.
  • Over-reading hemangioblastoma as the primary differential: hemangioblastomas typically lack calcification, have non-enhancing cyst walls, and show smaller mural nodules with angiographic blush.
  • Assuming completely solid presentations are atypical: ~17% of pilocytic astrocytomas are completely solid, and heterogeneous mixed solid-cystic variants occur in ~16% of cases, so morphologic variation does not exclude diagnosis.
Source: Reference source

Secondary Links

HomePediatricsAnatomyGeneral Resources